Applied Therapeutics, Inc. - Common Stock (APLT)

Historical Holders from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
APLT on Nasdaq
Shares outstanding
143,223,667
Price per share
$0.0958
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
94,763,328
Holdings value
$57,199,408
% of all portfolios
0%
Share change
+6,708,167
Value change
+$5,274,176
Average buys %
+0%
Average sells %
-0%
Number of holders
69
Price from insider filings
$0.1120
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Applied Therapeutics, Inc. - Common Stock (APLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 15% +13% $12,946,856 +$1,644,911 21,403,300 +15% T. Rowe Price Investment Management, Inc. 30 Sep 2025
Vestal Point Capital, LP 9.9% $4,485,000 11,500,000 Vestal Point Capital, LP 31 Dec 2024
Alyeska Investment Group, L.P. 5.8% $2,615,924 6,707,497 Alyeska Investment Group, L.P. 31 Dec 2024
ALEXANDRIA REAL ESTATE EQUITIES, INC. 4.3% $1,755,000 6,500,000 Alexandria Real Estate Equities, Inc. 11 Dec 2025
Propel Bio Management, LLC 4.2% $1,564,002 6,015,394 Propel Bio Management, LLC 29 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.1% -58% $2,171,407 -$2,432,661 5,567,709 -53% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
BlackRock, Inc. 3.7% -54% $1,003,183 -$783,523 5,219,475 -44% BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 3.3% -34% $1,473,225 -$359,492 4,734,013 -20% The Vanguard Group 30 Jun 2025
Schonfeld Strategic Advisors LLC 3.3% -53% $1,823,678 -$1,596,482 4,676,097 -47% Schonfeld Strategic Advisors LLC 31 Mar 2025
PERCEPTIVE ADVISORS LLC 2.4% $1,115,400 2,860,000 Perceptive Advisors LLC 31 Dec 2024
MORGAN STANLEY 2.5% -64% $1,114,983 -$2,323,072 2,858,931 -68% Morgan Stanley 31 Jan 2025
FRANKLIN RESOURCES INC 1.7% -70% $781,326 -$1,871,029 2,003,400 -71% Franklin Resources, Inc. 31 Dec 2024
JANUS HENDERSON GROUP PLC 0% -104% $13,958 -$4,706,957 35,791 -100% JANUS HENDERSON GROUP PLC 31 Dec 2024
As of 30 Sep 2025, Applied Therapeutics, Inc. - Common Stock (APLT) has 69 institutional shareholders filing 13F forms. They hold 94,763,328 shares of 143,223,667 outstanding shares (66%) .

Top 25 institutional shareholders own 65% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 15% 21,403,300 +15% 0.01% $12,842,000
Vestal Point Capital, LP 9.9% 14,250,000 +24% 0.39% $8,619,825
Propel Bio Management, LLC 7.9% 11,285,420 0% 6.8% $6,826,551
Knoll Capital Management, LLC 5.4% 7,799,687 0% 2.5% $4,711,010
VANGUARD GROUP INC 3.6% 5,102,689 +7.8% 0% $3,087,126
Simplify Asset Management Inc. 3.1% 4,487,505 0% 0.06% $2,714,492
BlackRock, Inc. 2.7% 3,843,733 -26% 0% $2,325,074
PNC Financial Services Group, Inc. 2% 2,901,184 0% $1,755,216
Pathstone Holdings, LLC 1.8% 2,643,540 0% 0.01% $1,599,077
MARSHALL WACE, LLP 1.8% 2,542,688 +65% 0% $1,525,612
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.5% 2,211,629 +83% 0% $1,337,814
Rock Springs Capital Management LP 1.4% 2,075,991 0% 0.07% $1,255,767
FRANKLIN RESOURCES INC 1.4% 2,003,338 0% 0% $1,211,819
MILLENNIUM MANAGEMENT LLC 1.3% 1,907,214 -1.9% 0% $1,153,674
UBS Group AG 1.3% 1,905,625 +129% 0% $1,152,903
GEODE CAPITAL MANAGEMENT, LLC 0.89% 1,278,156 +32% 0% $773,417
Qube Research & Technologies Ltd 0.81% 1,167,269 -36% 0% $706,081
MORGAN STANLEY 0.5% 713,314 +108% 0% $431,484
Hudson Bay Capital Management LP 0.47% 673,764 0% $407,560
DEUTSCHE BANK AG\ 0.43% 622,226 -0% 0% $379,558
STATE STREET CORP 0.36% 518,518 +47% 0% $313,652
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.33% 477,157 -19% 0% $288,632
Rockefeller Capital Management L.P. 0.27% 391,897 0% $237,058
Hennion & Walsh Asset Management, Inc. 0.2% 282,848 -1.8% 0.01% $171,095
Birchview Capital, LP 0.16% 225,000 -20% 0.1% $136,103

Institutional Holders of Applied Therapeutics, Inc. - Common Stock (APLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 41,748 $4,000 +$2,428 $0.0958 1
2025 Q3 94,763,328 $57,199,408 +$5,274,176 $0.6049 69
2025 Q2 88,058,885 $27,371,087 -$7,459,469 $0.3111 72
2025 Q1 106,044,815 $51,845,704 -$6,334,916 $0.4889 89
2024 Q4 115,065,005 $98,537,797 -$63,025,089 $0.8562 116
2024 Q3 112,721,874 $960,819,113 +$78,176,113 $8.50 125
2024 Q2 103,226,978 $481,702,267 +$36,985,908 $4.67 92
2024 Q1 93,958,967 $638,614,949 +$241,302,453 $6.80 88
2023 Q4 61,449,532 $205,844,085 +$29,840,415 $3.35 83
2023 Q3 42,970,428 $106,996,842 +$29,101,733 $2.49 54
2023 Q2 31,465,661 $40,275,555 +$15,796,729 $1.28 38
2023 Q1 19,276,965 $15,634,509 -$232,317 $0.8111 34
2022 Q4 19,679,561 $15,064,959 -$2,201,503 $0.7600 37
2022 Q3 22,671,560 $21,085,673 -$3,749,758 $0.9301 38
2022 Q2 26,706,667 $25,318,845 +$12,989,524 $0.9481 46
2022 Q1 12,347,239 $26,037,310 -$34,487,329 $2.11 68
2021 Q4 14,922,342 $133,548,279 -$7,772,547 $8.95 67
2021 Q3 15,108,904 $250,903,236 -$6,255,939 $16.60 66
2021 Q2 15,367,633 $319,342,764 +$10,194,603 $20.78 68
2021 Q1 14,854,223 $278,593,752 +$51,374,327 $18.76 66
2020 Q4 12,104,777 $266,428,658 -$1,610,604 $22.01 67
2020 Q3 12,195,771 $253,182,315 -$6,258,655 $20.76 66
2020 Q2 11,427,491 $412,583,649 +$78,213,106 $36.15 71
2020 Q1 9,645,977 $315,329,165 +$155,281,170 $32.69 62
2019 Q4 4,991,742 $136,175,281 +$71,201,517 $27.28 45
2019 Q3 2,395,520 $26,326,659 +$2,265,568 $10.99 29
2019 Q2 2,195,975 $18,095,000 +$18,095,000 $8.24 13